Actively Recruiting
Dietary Peanuts and Nutrition-Related Outcomes
Led by Ian J. Neeland, MD · Updated on 2026-04-23
64
Participants Needed
1
Research Sites
84 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding peanuts to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating peanuts improves overall diet quality and health markers like tiredness and certain levels in blood.
CONDITIONS
Official Title
Dietary Peanuts and Nutrition-Related Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals with a BMI 630 kg/m2 or with a BMI 627 kg/m2 with at least one weight-related comorbidity
- Have been using semaglutide or tirzepatide for a clinical indication for at least 6 months
- Age between 18 and 80 years
You will not qualify if you...
- No use or contraindication to use of a GLP-1 receptor agonist
- Known allergy to nuts
- Pregnant or breastfeeding
- Incarcerated
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospitals Cleveland Medical Center
Clevland, Ohio, United States, 44106
Actively Recruiting
Research Team
I
Ian Neeland, MD
CONTACT
A
Abigail Raffner, PhD, RD, LD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here